Tissue-type plasminogen activator mutants. Theoretical and clinical considerations.
Bang
N U
NU
Lilly Laboratories for Clinical Research, Eli Lilly and Company, Indianapolis, IN.
D006801:Humans; D009154:Mutation; D011994:Recombinant Proteins / Q000235:genetics / Q000493:pharmacokinetics / Q000627:therapeutic use; D010959:Tissue Plasminogen Activator / Q000235:genetics* / Q000493:pharmacokinetics / Q000627:therapeutic use
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator